Recruiting NA Ventricular Tachycardia

New treatment option for Ventricular Tachycardia

Official title Ventricular Tachycardia Mechanisms

ClinicalTrials.gov ID: NCT05478213

What this study is testing

What it's testing
The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Diagnosis of ischemic cardiomyopathy
  • Single or dual chamber implantable cardioverter-defibrillator (ICD)

You likely can't join if

  • Non-Ischemic cardiomyopathy
  • Contraindication to catheter ablation
  • Severe peripheral arterial disease or medical condition that prohibit arterial access
  • Ventricular tachycardia (VT) or sudden cardiac arrest (SCA) within 30 days of acute coronary syndrome or within 90 days of coronary revascularization

The study team makes the final eligibility decision.

Where it's taking place

  • Atlanta, Georgia, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.